Identification of α-1L Adrenoceptor in Rabbit Ear Artery
暂无分享,去创建一个
[1] M. Kunitomo,et al. Alpha‐1D adrenoceptors are involved in reserpine‐induced supersensitivity of rat tail artery , 2004, British journal of pharmacology.
[2] Li Zhang,et al. Alpha‐1 adrenoceptors: evaluation of receptor subtype‐binding kinetics in intact arterial tissues and comparison with membrane binding , 2004, British journal of pharmacology.
[3] M. Michel,et al. Classification of α1-adrenoceptor subtypes , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[4] W. Schütz,et al. Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[5] I. Muramatsu,et al. Pharmacological profiles of a novel α1-adrenoceptor agonist, PNO-49 B, at α1-adrenoceptor subtypes , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[7] J. Guillebaud,et al. Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens , 2002, British journal of pharmacology.
[8] Y. Akagi,et al. Distribution of alpha‐1 adrenoceptor subtypes in RNA and protein in rabbit eyes , 2002, British journal of pharmacology.
[9] J. Faber,et al. Expression of α-Adrenoceptor Subtypes by Smooth Muscle Cells and Adventitial Fibroblasts in Rat Aorta and in Cell Culture , 2001 .
[10] J. Faber,et al. Expression of alpha-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. , 2001, The Journal of pharmacology and experimental therapeutics.
[11] G. Michelotti,et al. α1-Adrenergic receptor regulation: basic science and clinical implications , 2000 .
[12] J. Pediani,et al. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.
[13] J. Hieble,et al. Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. , 2000, Pharmaceutica acta Helvetiae.
[14] J. Docherty,et al. Investigation of the subtypes of α1‐adrenoceptor mediating contractions of rat vas deferens , 1999 .
[15] Y. Akagi,et al. Evaluation of α1‐adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA , 1999, British journal of pharmacology.
[16] T. Taniguchi,et al. Pharmacological analysis of the novel, selective α1‐adrenoceptor antagonist, KMD‐3213, and its suitability as a tritiated radioligand , 1999, British journal of pharmacology.
[17] Y. Watanabe,et al. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate. , 1999, European journal of pharmacology.
[18] T. Taniguchi,et al. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin. , 1998, Japanese journal of pharmacology.
[19] Y. Watanabe,et al. Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. , 1998, Life sciences.
[20] J. Coleman,et al. Tumour necrosis factor‐α expression and cell recruitment in Sephadex particle‐induced lung inflammation: effects of dexamethasone and cyclosporin A , 1997, British journal of pharmacology.
[21] J. Hieble,et al. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. , 1997, The Journal of pharmacology and experimental therapeutics.
[22] J. Blagg,et al. Pharmacological options in the treatment of benign prostatic hyperplasia. , 1997, Journal of medicinal chemistry.
[23] Ming Yang,et al. Is α1D-adrenoreptor protein detactable in rat tissues? , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[24] A. Ford,et al. Pharmacological characterization of an α1A‐adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat , 1997, British journal of pharmacology.
[25] I. Dougall,et al. Pharmacological classification of α1‐adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta , 1997, British journal of pharmacology.
[26] J. Hieble,et al. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. , 1997, The Journal of pharmacology and experimental therapeutics.
[27] Astra Charnwood. Pharmacological classification of a 1 -adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta , 1997 .
[28] M. Michel,et al. Is alpha1D-adrenoceptor protein detectable in rat tissues? , 1997, Naunyn-Schmiedeberg's archives of pharmacology.
[29] A. Hancock. α1 Adrenoceptor subtypes: A synopsis of their pharmacology and molecular biology , 1996 .
[30] T. Stamey,et al. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. , 1996, Molecular pharmacology.
[31] I. Muramatsu,et al. Identification of alpha 1-adrenoceptor subtypes in the rabbit prostate. , 1995, Journal of autonomic pharmacology.
[32] R. Lefkowitz,et al. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. , 1995, Pharmacological reviews.
[33] A. Goetz,et al. BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors , 1995 .
[34] A. Goetz,et al. BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. , 1995, European journal of pharmacology.
[35] I. Muramatsu,et al. Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes. , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[36] H. Akino,et al. Pharmacological characterization of alpha 1-adrenoceptor subtypes in the human prostate: functional and binding studies. , 1994, British journal of urology.
[37] D. Bylund,et al. Radioligand binding methods: practical guide and tips. , 1994, The American journal of physiology.
[38] I. Muramatsu,et al. Pharmacological characterization of two distinct α1‐adrenoceptor subtypes in rabbit thoracic aorta , 1993, British journal of pharmacology.
[39] I. Muramatsu,et al. Identification of α1‐adrenoceptor subtypes in the rat vas deferens: binding and functional studies , 1992 .
[40] I. Muramatsu,et al. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. , 1992, British Journal of Pharmacology.
[41] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[42] R. Furchgott. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .
[43] H. Schild,et al. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.